NEW DELHI — India’s healthcare system has undergone a “paradigm shift” toward self-reliance, affordability, and modernization, Defence Minister Rajnath Singh declared on Wednesday, citing recent advancements in medical research, vaccine production, and rural healthcare access. Speaking at the inauguration of a new research facility in Uttar Pradesh, Singh framed the country’s pandemic response and policy reforms as evidence of a “people-centric” transformation. Yet, while the government touts progress, independent health experts and opposition leaders argue that systemic challenges—including underfunding, workforce shortages, and regional disparities—continue to undermine equitable access to quality care.
What Happened
Addressing scientists, policymakers, and healthcare professionals at the event, Singh outlined a series of government-led initiatives that he said had strengthened India’s healthcare infrastructure. Key achievements highlighted in his speech included:
– Vaccine self-sufficiency: India’s rapid development and large-scale production of COVID-19 vaccines, including Covaxin and Covishield, which were exported to over 100 countries under the “Vaccine Maitri” program.
– Domestic medical manufacturing: Expansion of local production of pharmaceuticals, medical devices, and diagnostic kits, reducing reliance on imports.
– Rural healthcare expansion: The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the world’s largest government-funded health insurance scheme, which provides coverage to over 500 million people, and the establishment of 157 new medical colleges since 2014.
– Digital health initiatives: The rollout of the Ayushman Bharat Digital Mission, which aims to create a unified health database for citizens, and the e-Sanjeevani telemedicine platform, which has facilitated over 140 million consultations.
Singh’s remarks were framed within the broader “Atmanirbhar Bharat” (self-reliant India) campaign, a flagship policy of the Narendra Modi-led government that emphasizes reducing dependence on foreign imports across sectors, including healthcare. “India is setting new benchmarks in medical research and healthcare delivery,” Singh said, according to a report in The Hindu. “Our response to the pandemic demonstrated our ability to innovate, manufacture, and distribute life-saving solutions at scale.”
Why It Matters
India’s healthcare system serves a population of 1.4 billion, making it one of the largest and most complex in the world. The government’s claims of progress carry significant implications for public health, economic resilience, and geopolitical influence:
– Economic and strategic autonomy: Reduced dependence on imported medical supplies and pharmaceuticals could insulate India from global supply chain disruptions, a vulnerability exposed during the pandemic. The country is already the world’s largest producer of generic drugs, supplying nearly 20% of global demand by volume.
– Public health outcomes: Improved access to healthcare, particularly in rural areas, could address long-standing inequities. India accounts for nearly 17% of global maternal deaths and 20% of child mortality, according to UN data, with rural populations disproportionately affected.
– Global health leadership: India’s role in supplying vaccines and medicines to low- and middle-income countries has bolstered its diplomatic influence. The country’s pharmaceutical exports reached $25.3 billion in 2025, up from $17.3 billion in 2020, per Commerce Ministry data.
– Political messaging: Singh’s speech aligns with the ruling Bharatiya Janata Party’s (BJP) narrative ahead of the 2026 general elections, emphasizing self-reliance and welfare schemes as key achievements.
However, the government’s optimism contrasts sharply with critiques from health experts, opposition parties, and international organizations, who argue that India’s healthcare system remains plagued by structural weaknesses.
Background and Context
India’s healthcare system operates under a dual public-private model, with the government responsible for primary and secondary care while the private sector dominates tertiary care. Key historical and policy milestones include:
– Pre-2014 landscape: Before the BJP’s rise to power, India’s public health spending hovered around 1% of GDP, among the lowest in the world. The system was characterized by underfunded public hospitals, a severe shortage of medical professionals, and stark urban-rural divides.
– Post-2014 reforms: The Modi government introduced several flagship schemes, including:
– Ayushman Bharat (2018): Aims to provide health insurance coverage of up to ₹5 lakh ($6,000) per family annually for secondary and tertiary care.
– Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP): Launched in 2008 but expanded under the BJP, this scheme provides generic medicines at 50-90% lower prices than branded equivalents.
– National Health Mission (NHM): Focuses on strengthening primary healthcare infrastructure, particularly in rural and underserved areas.
– Pandemic response: India’s COVID-19 vaccination drive, which administered over 2.2 billion doses by 2025, was one of the largest in the world. The country also became a major supplier of vaccines to COVAX, the global vaccine-sharing initiative.
Despite these efforts, India’s healthcare system faces persistent challenges:
– Underfunding: Public health expenditure remains at 1.3% of GDP, far below the global average of 6% and the World Health Organization’s (WHO) recommended 5%. The government has pledged to increase this to 2.5% by 2025, but progress has been slow.
– Workforce shortages: India has just 0.8 doctors per 1,000 people, below the WHO’s recommended ratio of 1:1,000. The country also faces a critical shortage of nurses and paramedical staff, with rural areas particularly underserved.
– Regional disparities: States like Kerala and Tamil Nadu boast healthcare indicators comparable to developed nations, while Bihar and Uttar Pradesh lag behind, with high maternal and child mortality rates.
– Quality of care: Public hospitals are often overcrowded and understaffed, leading to long wait times and poor patient outcomes. A 2024 study by the Lancet found that India ranked 145th out of 195 countries in healthcare quality and access.
Competing Claims and Uncertainty
Singh’s assertion of a “self-reliant” healthcare system is contested by multiple stakeholders:
Government’s Position:
– The BJP government points to data showing increased domestic production of medical devices (e.g., ventilators, oxygen concentrators) and pharmaceuticals. For instance, India’s production of active pharmaceutical ingredients (APIs) grew by 30% between 2020 and 2025, reducing import dependence from 80% to 50% in some segments.
– The Ayushman Bharat scheme has provided over 250 million hospital admissions since its launch, with the government claiming it has saved families ₹1.25 lakh crore ($15 billion) in out-of-pocket expenses.
– Digital health initiatives, such as the Ayushman Bharat Digital Mission, have enrolled over 500 million citizens, creating a unified health database.
Critics’ Counterarguments:
– Opposition parties: Congress leader Rahul Gandhi has accused the government of “cherry-picking data” to mask systemic failures. He cited a 2025 report by the Comptroller and Auditor General (CAG) that found 30% of Ayushman Bharat empanelled hospitals had not provided any services, and many beneficiaries were denied coverage due to bureaucratic hurdles.
– Health experts: Dr. K. Srinath Reddy, president of the Public Health Foundation of India (PHFI), argued that while India has made progress in specific areas, “the overall system remains fragmented and underfunded.” He noted that out-of-pocket health expenditures still account for 48% of total health spending, among the highest in the world.
– International reports: The WHO’s 2025 Global Health Expenditure Report ranked India 154th out of 195 countries in healthcare access and quality. The report highlighted that while India had improved its score since 2015, it still lagged behind neighbors like Sri Lanka and Bangladesh in key indicators.
– Rural-urban divide: A 2026 study by the Indian Journal of Public Health found that 60% of rural Indians still lack access to basic healthcare services within a 5-kilometer radius, compared to 20% in urban areas.
Areas of Uncertainty:
– Impact of digital health initiatives: While the Ayushman Bharat Digital Mission has enrolled millions, its effectiveness in improving health outcomes remains unclear. Critics argue that digital divides—particularly in rural areas with poor internet connectivity—could exacerbate inequities.
– Sustainability of self-reliance: India’s pharmaceutical industry remains heavily dependent on China for APIs, with 60-70% of key ingredients still imported. The government’s Production-Linked Incentive (PLI) scheme aims to boost domestic API production, but its long-term success is yet to be proven.
– Quality vs. quantity: The expansion of medical colleges has increased the number of doctors, but concerns persist about the quality of medical education. A 2025 report by the National Medical Commission (NMC) found that 30% of newly minted doctors failed basic competency exams.
What to Watch Next
Several developments will shape the trajectory of India’s healthcare system in the coming months and years:
1. Budget 2026-27: The government’s allocation for healthcare will be closely scrutinized. While the 2025-26 budget increased health spending by 12%, experts argue that a sustained increase to at least 2.5% of GDP is necessary to meet global standards.
2. Ayushman Bharat 2.0: The government is reportedly planning to expand the scheme to cover primary and preventive care, including outpatient services. If implemented, this could address a major gap in the current system, which focuses primarily on hospitalization.
3. Pharmaceutical self-reliance: The success of the PLI scheme in reducing API imports will be a key indicator of India’s progress toward self-sufficiency. The government has set a target of reducing API imports by 50% by 2030.
4. State-level reforms: Healthcare is a state subject in India, and the performance of state governments will be critical. States like Kerala and Tamil Nadu, which have prioritized health spending, could serve as models for others.
5. Global health partnerships: India’s role in global health initiatives, such as vaccine diplomacy and pandemic preparedness, will be tested as the country seeks to position itself as a leader in the Global South.
6. Private sector role: The government’s push for public-private partnerships (PPPs) in healthcare could either improve access or exacerbate commercialization. The outcomes of ongoing PPP projects in states like Uttar Pradesh and Maharashtra will be closely watched.
Conclusion
Defence Minister Rajnath Singh’s remarks underscore the government’s narrative of a healthcare system transformed by self-reliance, innovation, and expanded access. The achievements—particularly in vaccine production, digital health, and insurance coverage—are undeniable and reflect India’s growing capabilities in a critical sector. However, the claims of a “paradigm shift” must be weighed against persistent challenges: chronic underfunding, workforce shortages, regional disparities, and the lingering burden of out-of-pocket expenses.
India’s healthcare journey is at a crossroads. The pandemic demonstrated the country’s potential to innovate and scale solutions rapidly, but it also exposed deep-seated vulnerabilities. The path forward will require not just increased funding, but also systemic reforms to address quality gaps, workforce shortages, and inequities. As the
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: The Hindu – National — source.
